Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Seimiya

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
The Journal of Biological Chemistry|February 14, 1997
c-Jun NH2-terminal kinase-mediated activation of interleukin-1beta converting enzyme/CED-3-like protease during anticancer drug-induced apoptosisH Seimiya, T Mashima, M Toho, et al.
Cytotechnology|November 13, 2008
Apoptosis resistance in tumor cellsT Mashima, H Seimiya, Z Chen, et al.
Oncogene|September 23, 2008
Promotion of glioma cell survival by acyl-CoA synthetase 5 under extracellular acidosis conditionsT Mashima, S Sato, Y Sugimoto, et al.
International Journal of Cancer|April 9, 1998
2-Deoxyglucose inhibits chemotherapeutic drug-induced apoptosis in human monocytic leukemia U937 cells with inhibition of c-Jun N-terminal kinase 1/stress-activated protein kinase activationN Haga, M Naito, H Seimiya, et al.
International Journal of Cancer|July 9, 1993
M-CSF gene transduction in multidrug-resistant human cancer cells to enhance anti-P-glycoprotein antibody-dependent macrophage-mediated cytotoxicityY Heike, S Sone, S Yano, et al.
Oncology Research|January 1, 1995
Difference between the resistance mechanisms of aclacinomycin- and adriamycin-resistant P388 cell linesJ Dong, M Naito, T Tatsuta, et al.
ESMO Gastrointestinal Oncology|April 23, 2026
Preclinical identification and clinical validation of dynamic biomarkers for trifluridine/tipiracil with or without bevacizumab in metastatic colorectal cancerM Suenaga, T Mashima, N Kawata, et al.
Oncogene|February 18, 1999
Activation of c-Abl tyrosine kinase requires caspase activation and is not involved in JNK/SAPK activation during apoptosis of human monocytic leukemia U937 cellsS Dan, M Naito, H Seimiya, et al.
The Journal of Antibiotics|September 1, 1995
Inhibition of the association with nuclear matrix of pRB, p70 and p40 proteins along with the specific suppression of c-MYC expression by geldanamycin, an inhibitor of Src tyrosine kinaseH Yamaki, M Nakajima, H Seimiya, et al.
Cancer Research|May 15, 1995
Involvement of CD45 in adhesion and suppression of apoptosis of mouse malignant T-lymphoma cellsK Hanaoka, N Fujita, S H Lee, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
The Journal of Biological Chemistry|February 14, 1997
c-Jun NH2-terminal kinase-mediated activation of interleukin-1beta converting enzyme/CED-3-like protease during anticancer drug-induced apoptosisH Seimiya, T Mashima, M Toho, et al.
Cytotechnology|November 13, 2008
Apoptosis resistance in tumor cellsT Mashima, H Seimiya, Z Chen, et al.
Oncogene|September 23, 2008
Promotion of glioma cell survival by acyl-CoA synthetase 5 under extracellular acidosis conditionsT Mashima, S Sato, Y Sugimoto, et al.
International Journal of Cancer|April 9, 1998
2-Deoxyglucose inhibits chemotherapeutic drug-induced apoptosis in human monocytic leukemia U937 cells with inhibition of c-Jun N-terminal kinase 1/stress-activated protein kinase activationN Haga, M Naito, H Seimiya, et al.
International Journal of Cancer|July 9, 1993
M-CSF gene transduction in multidrug-resistant human cancer cells to enhance anti-P-glycoprotein antibody-dependent macrophage-mediated cytotoxicityY Heike, S Sone, S Yano, et al.
Oncology Research|January 1, 1995
Difference between the resistance mechanisms of aclacinomycin- and adriamycin-resistant P388 cell linesJ Dong, M Naito, T Tatsuta, et al.
ESMO Gastrointestinal Oncology|April 23, 2026
Preclinical identification and clinical validation of dynamic biomarkers for trifluridine/tipiracil with or without bevacizumab in metastatic colorectal cancerM Suenaga, T Mashima, N Kawata, et al.
Oncogene|February 18, 1999
Activation of c-Abl tyrosine kinase requires caspase activation and is not involved in JNK/SAPK activation during apoptosis of human monocytic leukemia U937 cellsS Dan, M Naito, H Seimiya, et al.
The Journal of Antibiotics|September 1, 1995
Inhibition of the association with nuclear matrix of pRB, p70 and p40 proteins along with the specific suppression of c-MYC expression by geldanamycin, an inhibitor of Src tyrosine kinaseH Yamaki, M Nakajima, H Seimiya, et al.
Cancer Research|May 15, 1995
Involvement of CD45 in adhesion and suppression of apoptosis of mouse malignant T-lymphoma cellsK Hanaoka, N Fujita, S H Lee, et al.
Pageof 4